GB Meka
Stocks to watch

NBIX

Compare

NEUROCRINE BIOSCIENCES INC · Healthcare

$139.55
▲ 0.9%Close 2026-09-30

Live intraday price

Compare with our price levels

T2147.45
T1142.82
E1133.18
E3125.95
SL121.93

Close 2026-09-30: $139.55 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positive

Not in the buy zone yet — needs to drop 4.6% · 1 whale recently bought

1 month
▼ 9.4%
3 months
▼ 16.8%
1 year
▼ 0.5%
Analyst target
$208.40 +49.3%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$133.18 -4.6%
E2$129.17 -7.4%
E3$125.95 -9.7%
Targets
T1$142.82 2.3%
T2$147.45 5.7%
T3$149.98 7.5%
Stop-loss
SL$121.93 -12.6%
Whale cost ~$139.12 -0.3%

Risk : reward 1 : 2.4Moves ~$4.02 a day

⚖️ Positives and risks

✓ Positives (4)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 208.40 (upside +49%, 29 ราย)
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Strong Buy
  • ●รายได้โต +40% เทียบปีก่อน
! Risks (1)
  • ●อ่อนแอกว่าตลาด (S&P 500) -13% ใน 6 เดือน

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

ABERNETHY MATT · CFO

2026-09-14 · 2,311 shares @ $157.20 · pre-planned sale (10b5-1)

$363,285
Sell

Boyer David W. · Officer

2026-09-14 · 826 shares @ $157.45 · pre-planned sale (10b5-1)

$130,051
Sell

BENEVICH ERIC · Officer

2026-09-09 · 2,154 shares @ $154.61 · pre-planned sale (10b5-1)

$333,030
Sell

Norwalk Leslie V · Director

2026-07-28 · 1,250 shares @ $182.01 · pre-planned sale (10b5-1)

$227,508
Sell

Delaet Ingrid · Officer

2026-07-10 · 4,367 shares @ $181.02 · pre-planned sale (10b5-1)

$790,514
Sell

Lippoldt Darin · Officer

2026-07-09 · 10,000 shares @ $179.60 · pre-planned sale (10b5-1)

$2M
Sell

Delaet Ingrid · Officer

2026-07-09 · 8,433 shares @ $178.72 · pre-planned sale (10b5-1)

$2M
Sell

Delaet Ingrid · Officer

2026-07-08 · 2,737 shares @ $178.54 · pre-planned sale (10b5-1)

$488,672
Sell

Delaet Ingrid · Officer

2026-07-07 · 3,401 shares @ $178.57 · pre-planned sale (10b5-1)

$607,305
Sell

Lippoldt Darin · Officer

2026-06-29 · 8,110 shares @ $170.03 · pre-planned sale (10b5-1)

$1M
Sell

Lippoldt Darin · Officer

2026-06-29 · 1,690 shares @ $170.81 · pre-planned sale (10b5-1)

$288,676
Sell

Lippoldt Darin · Officer

2026-06-26 · 200 shares @ $169.57 · pre-planned sale (10b5-1)

$33,913
Sell

SHERWIN STEPHEN A · Director

2026-06-05 · 7,883 shares @ $163.81 · pre-planned sale (10b5-1)

$1M
Sell

SHERWIN STEPHEN A · Director

2026-06-05 · 6,896 shares @ $165.79 · pre-planned sale (10b5-1)

$1M
Sell

SHERWIN STEPHEN A · Director

2026-06-05 · 5,829 shares @ $166.56 · pre-planned sale (10b5-1)

$970,859

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-07-30Beat +45%

Actual EPS $2.85 · est. $1.96 · After close

▼ 10.1%

Day 1

-7.6%

Next 20 days

2026-05-05Beat +14%

Actual EPS $1.94 · est. $1.70 · After close

▲ 8.9%

Day 1

+13.8%

Next 20 days

2026-02-11Miss -18%

Actual EPS $1.88 · est. $2.30 · After close

▼ 10.4%

Day 1

+5.4%

Next 20 days

2025-10-28In line +5%

Actual EPS $2.17 · est. $2.07 · After close

▼ 6.4%

Day 1

+9.8%

Next 20 days

2025-07-30Beat +10%

Actual EPS $1.65 · est. $1.50 · After close

▼ 6.2%

Day 1

+8.4%

Next 20 days

2025-05-05Miss -36%

Actual EPS $0.70 · est. $1.09 · After close

▲ 8.4%

Day 1

+4.7%

Next 20 days

2025-02-06Miss -12%

Actual EPS $1.69 · est. $1.93 · After close

▼ 18.5%

Day 1

-9.6%

Next 20 days

2024-10-30In line -0%

Actual EPS $1.81 · est. $1.82 · Before open

▲ 7.0%

Day 1

+1.8%

Next 20 days

Listen to the earnings call or read the full report on NBIX's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$14.1B
Next earnings2026-10-28
P/E (price to earnings)20.2
Forward P/E (on expected earnings)11.6
Revenue growth (YoY)+39.5%
Earnings growth (YoY)+31.1%
Net profit margin+20.9%
ROE+22.1%
Debt to equity (D/E)12%
Dividend yield-
Analyst targets (high / low)$253.00 / $164.00
Number of analysts29
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Downtrend ↘ · Sideways →
RSI32
MA50 / MA200$156.87 / $147.38
Distance from MA200-5.3%
MACDNegative
1-year high / low$186.12 / $122.14
vs. S&P 500 (6 months)-12.8%
Volume vs. average0.19×